Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, Liver Disease and Transplantation, and Diabetes, Cardiovascular Risks, and Lipoproteins.
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study
The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease
Obesity Is a Risk Factor for Greater COVID-19 Severity
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
Patients with diabetes are at higher risk for severe illness from COVID-19
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
Metabolic‐associated fatty liver disease is associated with severity of COVID‐19
Fatal outcome in a liver transplant recipient with COVID-19
Clinical utility of the MAFLD definition
COVID‐19 and liver transplantation: Lessons learned from three reported cases
Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications
<i>PNPLA3</i> rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels